Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 2 Patients

Condition:   SMA II Intervention:   Genetic: GC101 Sponsor:   GeneCradle Inc Not yet recruiting

Source: ClinicalTrials.gov - June 13, 2023 Category: Research Source Type: clinical trials